|
RPAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73483449827927E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.43121103646627E-13 |
| Normal-vs-Stage2 |
6.04730000000053E-05 |
| Normal-vs-Stage3 |
9.68100044573816E-11 |
| Normal-vs-Stage4 |
4.40159999559597E-08 |
| Stage1-vs-Stage2 |
1.437210E-01 |
| Stage1-vs-Stage3 |
5.054400E-01 |
| Stage1-vs-Stage4 |
8.090200E-01 |
| Stage2-vs-Stage3 |
9.484500E-02 |
| Stage2-vs-Stage4 |
2.041800E-01 |
| Stage3-vs-Stage4 |
8.165200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.27116153345742E-14 |
| Normal-vs-AfricanAmerican |
6.283900E-03 |
| Normal-vs-Asian |
9.34020000009639E-07 |
| Caucasian-vs-AfricanAmerican |
6.145900E-02 |
| Caucasian-vs-Asian |
3.498000E-01 |
| AfricanAmerican-vs-Asian |
3.234800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.06950054052413E-10 |
| Normal-vs-Female |
1.79956050061492E-12 |
| Male-vs-Female |
9.757400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.22566409746605E-12 |
| Normal-vs-Age(41-60Yrs) |
3.37920025295091E-10 |
| Normal-vs-Age(61-80Yrs) |
2.23970000323703E-08 |
| Normal-vs-Age(81-100Yrs) |
1.376670E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.494000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.929800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.699400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.096200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.732600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.339600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.383520E-03 |
| Classical-VS-Follicular |
5.992400E-01 |
| Classical-VS-Other |
7.529400E-01 |
| Classical-VS-Normal |
1.49670276172742E-11 |
| Tall-VS-Follicular |
2.033900E-02 |
| Tall-VS-Other |
4.563800E-01 |
| Tall-VS-Normal |
7.32414129345216E-12 |
| Follicular-VS-Other |
9.049400E-01 |
| Follicular-VS-Normal |
1.97499999687878E-08 |
| Other-VS-Normal |
7.535400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60820023964448E-10 |
| Normal-vs-N1 |
1.78912440418344E-12 |
| N0-vs-N1 |
1.665550E-02 |
|
|
